Close

Missouri Governor Nixon Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines


BIO and Missouri Biotechnology Association (MOBIO) commend Governor Jay Nixon for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.  

Virginia Governor Terry McAuliffe Presented 2016 BIO Governor of the Year Award

BIO today presented Virginia Governor Terry McAuliffe with its 2016 Governor of the Year award in recognition of his leadership and commitment to strengthening the biosciences industry within Virginia. Governor McAuliffe received the award at the 2016 BIO International Convention.

New Report Shares Best Practices for the Development of Disease-Specific Patient Preference Studies

 San Francisco, CA (June 8, 2016) – Today, the Biotechnology Innovation Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) released a new report, “Key Considerations for Developing and Integrating Patient Perspectives in Drug Development: Examination of the Duchenne Case Study.” 

New Report Shares Best Practices for the Development of Disease-Specific Patient Preference Studies

Today, the Biotechnology Innovation Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) released a new report, “Key Considerations for Developing and Integrating Patient Perspectives in Drug Development: Examination of the Duchenne Case Study.” 

National Bioscience Report Shows Industry Creating Jobs and Driving Innovation

Bioscience industry contributing to U.S. economic growth and improving quality of life for patients

BIO Welcomes New Industrial & Environmental Section Members

BIO today announced six companies have joined the Industrial & Environmental Section in the past year. The announcement was made following BIO’s Industrial & Environmental Section member meeting and election of governing board officers at the 2016 BIO International Convention in San Francisco. 

BIO Elects New Board Officers and Members

BIO is pleased to announce the election of two new Board Officers, several new Section Governing Board Chairs, and 21 new members of its Board of Directors, all voted upon at this year’s 2016 BIO International Convention.

Office of the National Coordinator for Health Information Technology; Medicare Access and CHIP Reauthorization Act of 2015; Request for Information (RFI) Regarding Assessing Interoperability for MACRA

The Biotechnology Innovation Organization (BIO) is pleased to submit the following comments in response to the Request for Information (RFI) Regarding Assessing Interoperability for MACRA (the “RFI”).1 BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO’s members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place. In that way, our members’ novel therapeutics, vaccines, and diagnostics not only have improved health outcomes, but also have reduced healthcare expenditures due to fewer physician office visits, hospitalizations, and surgical interventions.

BIO Brings Airgas® Products & Services to BIO Members

Washington, D.C. (June 2, 2016) – The Biotechnology Innovation Organization (BIO) has announced a new partnership with Airgas, an Air Liquide company and one of the nation’s leading suppliers of industrial, medical, and specialty gases, and related products, to add cylinder gases, bulk gases, dry ice and related supplies to the BIO Business Solutions® offerings. 

GM Crops Help Ensure Global Food Security Through Higher Crop Yields

Farmers around the world who use seeds improved with biotechnology continue to benefit economically while improving the environmental sustainability of their farming operations according to the report “GM Crops: Global Socio-Economic and Environmental Impacts 1996-2014” released by PG Economics.